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Abstract. Interleukin (IL)-8 is a pro-inflammatory cytokine 
that has a direct effect on immune cells, including polymor-
phonuclear cells. Keratinocytes are a rich source of IL-8. 
However, there is little knowledge on the role of IL-8 in clinical 
wound healing and the direct biological effect of IL-8 on kera-
tinocytes. In this study, the effect of recombinant human IL-8 
(rhIL-8) on migration and adhesion was tested using HaCaT 
keratinocytes as a cell model. The cell functions were evalu-
ated using impedance cell sensing. The expression of IL-8 
receptor (IL-8R) transcripts in human skin and wounds (acute 
and chronic) was assessed using real-time transcript analysis. 
rhIL-8 significantly increased the migration of keratinocytes 
(3.5±0.3 for cells treated with IL-8 vs. 2.7±0.6 for controls; 
p=0.029). It is interesting to note that treatment of keratino-
cytes with IL-8 resulted in a marked shift in the responsive 
frequencies. IL-8 only resulted in a marginal increase in cell 
adhesion, which was particularly noticeable at high frequen-
cies. The PLC-γ inhibitor completely eradicated the action of 
IL-8 on the migration of HaCaT cells. Using real time PCR, it 
was found that chronic wounds had significantly lower levels 
of the B form of the IL-8R (IL-8RB) (p=0.045) and marginally 
lower levels of the A form, IL-8RA, in comparison with acute 
wounds. Therefore, IL-8 has a direct and profound stimula-
tory effect on the migration of human keratinocytes, which is 
likely to occur via the PLC-γ pathway. Together with a reduced 
level of IL-8Rs in difficult-healing wounds, IL-8 has a clear 
prognostic and therapeutic value in wound healing.
Introduction
Interleukin (IL)-8, also known as neutrophil activating peptide, 
CXCL8, small inducible cytokine subfamily B (SCY88) and 
granulocyte chemotactic protein-1 (GCP-1), is a cytokine that 
belongs to the CXC chemokine family (1,2). IL-8 is a small 
protein that is encoded by the IL-8 gene, which is located on 
chromosome 4q12-q21 (3). IL-8 has been shown to be linked to 
a number of conditions including viral bronchiolitis (4-6), cystic 
fibrosis related pathophysiology of the lungs, infection and other 
inflammatory diseases, including rheumatoid arthritis (7). It 
plays a pivotal role in the pathophysiology of sepsis. IL-8 is a 
powerful chemoattractant for neutrophils, basophils and T cells, 
but not monocytes, although the latter is a rich source of IL-8.
The action of IL-8 is mediated by its receptor, IL-8R. IL-8R 
has two forms, IL-8RA and IL-8RB. IL-8RA is also known 
as chemokine, CXC motif, receptor-1 (CXCR1), or IL-8R1. 
IL-8RA is located on chromosome 2q35 (8,10). IL-8RB is 
also known as chemokine, CXC motif, receptor-2 (CXCR2) 
or IL-8R2 (8,9), and is located on chromosome 2q35. In the 
body, monocytes and fibroblasts are rich sources of IL-8. It was 
recently reported that the healing of diabetic and non-diabetic 
leg ulcers following treatment with Lactobacillus plantarum, 
increased such that, to a certain degree, it coincided with the 
increase in the IL-8 production of the polymorphonuclear cells 
in the wound base (11). It has also been shown that IL-8 has 
an impact on the migration of fibroblasts and endothelial cells. 
IL-8 has been found to be highly stained in keratino-
cytes (12). Keratinocytes increased the expression of IL-8 in 
response to inflammatory stimuli such as tissue plasminogen 
activator (tPA) (13). Other agents, include trypsin, which 
increases and salbutamol, which inhibits the production of 
IL-8 from keratinocytes (14). Gingko biloba extract also 
inhibits IL-8 secretion from keratinocytes (15). IL-8RA and 
IL-8RB have been found to be present in keratinocytes of the 
skin. IL-8 and IL-8R have also been shown to be co-expressed 
in gingival keratinocytes (16). In psoriasis, IL-8R has been 
found to be overexpressed in keratinocytes, which may be 
inhibited by FK-506, an anti-psoriasis compound (17).
The potential role of IL-8 as a cell migration and chemo-
taxis factor indicates a significant role in wound healing. 
Indeed, it has been demonstrated that IL-8 may be chemotactic 
for human keratinocytes, which express IL-8Rs (18). In animal 
models using IL-8RB knockout mice, there was a delayed rate 
of wound healing (19). This appears to be associated with a 
delay in monocyte recruitment to the wounding space and a 
delay in re-epithelialisation and angiogenesis.
The impact of IL-8 and the IL-8R in the context of chronic 
wounds and clinical wound healing have otherwise not been 
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well investigated. Chronic wounds represent a major health issue. 
Derived from multiple aetiology, including diabetes mellitus, 
pressure sores and circulation conditions, chronic wounds are 
costly to treat for the healthcare system. For example, in the UK, 
there are approximately 200,000 patients with chronic wounds at 
any given time, the care of which consumes more than 3% of the 
budget of the NHS. However, the biology of wound healing and, 
in particular, chronic wound healing are not yet fully understood. 
Wound healing is a complex biological process that requires 
temporal, special and co-ordinated action of multiple cell types, 
including immune cells for combating possible pathogens, fibro-
blasts for matrix deposition and remodelling, endothelial cells for 
the angiogenic process and keratinocytes for re-epithelialisation. 
IL-8 appears to play multiple roles in these processes.
In the present study, we investigated the transcript expression 
of IL-8RA and IL-8RB in a cohort of human wound tissues, and 
report the significant link between the cytokine complex and the 
fate of the wound. Furthermore, we have shown that IL-8 has a 
direct effect on the migration of human keratinocytes.
Materials and methods
Cells and tissues. The human keratinocyte cell line, HaCaT, 
was purchased from the German Cancer Institute and routinely 
maintained in Dulbecco's Modified Eagle's Medium (DMEM), 
supplemented with 10% fetal calf serum (FCS) and antibiotics. 
A cohort of fresh, frozen human wound tissues, acute wound 
tissues (n=10) and chronic wound tissues from venous ulcers 
(n=14), were collected under an Ethics Approval from clinics 
in the University Hospital of Wales, and used for histology and 
gene expression analysis, as previously reported (20,21).
Recombinant human IL-8 (rhIL-8) was obtained from 
NBSB (Potters Bar, England, UK). Antibodies to human 
IL-8RA and IL-8RB were from Santa Cruz Biotechnologies 
Inc. (Santa Cruz, CA, USA). ERK inhibitor II (FR180204) and 
PLC-γ inhibitor (U73122) were purchased from Calbiochem 
(Merck Chemicals Ltd, Nottingham, UK). FAK inhibitor was 
from Tocris (Bristol, England), and Arp2/3 inhibitor was from 
Chemidiv Ltd (San Diego, CA, USA).
Tissue processing and preparation of materials for protein and 
molecular investigations. Tissues were frozen and sectioned on 
a Leica cryostat at 5-10 µM thickness. The sections were divided 
into two portions: one section was processed for histological 
investigation and the other for extraction of genetic materials. 
For histological analysis, sections were laid on slides, prior to 
fixing and blocking by hydrogen peroxide and methanol. The 
section was then processed for H&E staining.
A large number of frozen sections were combined and 
homogenised using a homogenizer in a RNA isolation buffer 
(Triagent; Sigma-Aldrich, Poole, Dorset, UK). Total RNA was 
subsequently separated and quantified using a spectrophotometer. 
Quantitative analysis of IL-8RA and IL-8RB transcripts 
in cells and tissues. Total RNA was extracted from cell 
pellets using Triagent obtained from Sigma-Aldrich. Fresh 
frozen wound tissues were combined, resuspended in 
Triagent and homogenised using a hand-held homogeniser 
(Fisher Scientific). Total RNA was extracted and purified 
from the cells and tissue sections according to manufacturer's 
instructions. Equal amounts of RNA were reverse transcribed 
into complementary DNA (cDNA) using a first-strand reverse 
transcription (RT) kit from Bio-Rad (Hemel Hemstead, 
UK). For quantitative analysis of the IL-8R transcripts, we 
employed a real-time quantitative PCR assay, as previously 
reported (22-24). Briefly, primers (sequences shown in Table I) 
were designed using the Beacon Designer software and satis-
fied the following criteria: the amplified region sits on an 
exon-exon joint region and is specific to the respective target; 
the amplicon is smaller than 150 bp; a sequence that was 
complementary to the probe was added to one of the primers 
(routinely the reverse primer); and the annealing temperature 
is, or is close to being, 55˚C. The Ampliflor Uniprimer system 
was used as the probe system. cDNA from cells and tissues, 
together with a set of standards were amplified simultane-
ously, on a IcyclerIQ5 system (Bio-Rad). The concentration 
of the respective transcript was calculated from the standard 
curve, which was simultaneously generated. The levels of the 
transcripts are shown here as the respective transcript/glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) ratio.
Electric cell-substrate impedance sensing (ECIS)-based 
cell adhesion and cell migration assays. ECIS Ztheta and 
96W1E arrays were used (Applied Biophysics Inc, Troy, NY, 
USA) (23,25,26). Following treatment of the array surface with 
a cysteine solution, the arrays were incubated with complete 
medium for 1 h. The same number of HaCaT cells were added 
into each well, with or without IL-8 and small inhibitors. Cell 
adhesion was recorded immediately following addition of the 
cells, at multiple frequencies, for up to 6 h. For the cell migra-
tion assay, confluent HaCaT cells with or without IL-8, and 
small signalling inhibitors, were wounded for 20 sec at 6 V. 
The migration of the cells was immediately traced following 
wounding for up to 18 h, again with multiple frequencies. Cell 
behaviour was modelled using the Rb method, using a cell-free 
well as a reference unit. Cell migration and adhesion are shown 
here as the change in resistance.
Statistical analysis was carried out using Minitab. 
For normality test, the Anderson-Darling test was used, 
and for statistical differences the Student's t-test and Mann-
Whitney U test were used as appropriate.
Results
IL-8 markedly increased the migration of keratinocytes. Using 
electrical wounding methods, we first tested the impact of 
rhIL-8 on the migration of HaCaT cells following wounding. 
As seen in Fig. 1, IL-8 markedly increased the migration of 
the cells (Fig. 1).
Using 3-D cellular modelling, the differences between 
control and IL-8-treated cells were clearly visible (Fig. 2) with 
the maximum effects observed at a frequency of 4,000 Hz. 
This difference was statistically significant (p<0.01) (Fig. 2).
IL-8 had a significant effect on the adhesion of keratinocytes. 
We further tested to see whether IL-8 had an effect on the 
adhesion of keratinocytes to the matrix. Again, using the ECIS 
attachment method, we evaluated the rate of cell adhesion. As 
shown in Fig. 3, the presence of IL-8 markedly increased the 
adhesion of the cells.
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Potential signalling pathways in the action of IL-8. In order 
to explore potential pathways involved in the aforementioned 
action, we used a panel of small inhibitors to some of the known 
pathways downstream of the IL-8R. We have demonstrated 
that the PLC-γ inhibitor markedly inhibited the increased 
migration induced by IL-8, and brought the migration to the 
control level. The same inhibitor has an inhibitory effect on 
cell adhesion, although this is yet to reach significance (data 
not shown). The ERK inhibitor also had an inhibitory effect on 
the migration of keratinocytes, but did not completely elimi-
nate the action of IL-8. The FAK and ARP2/3 inhibitors had 
marginal effects (Fig. 4).
Human chronic wound tissues had a marked low level of 
IL-8RB. We investigated the transcript levels of the IL-8Rs, 
IL-8RA and IL-8RB in acute and chronic wound tissues. As 
shown in Fig. 5, there were significantly lower levels of IL-8RB 
in chronic wound tissues than in acute tissues (Fig. 5). Although 
the levels of IL-8RA tended to be lower, this was not statistically 
significant.
Table I. Primers used in the quantitative analysis of gene transcripts.





GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IL-8R, IL-8 receptor; IL, interleukin.
Figure 1. The effect of rhIL-8 on the migration of HaCaT cells. Confluent 
HaCaT cells in the 96W1E array were wounded for 20 sec at 6 V, following 
which the migration was immediately traced for up to 8 h over 12 frequencies 
[shown are (A) 1000, (B) 4000 and (C) 32000 Hz]. rhIL-8 markedly increased 
the pace of migration of the cells. rhIL-8, recombinant human IL-8.
Figure 2. Effect of rhIL-8 on cellular migration of HaCaT cells, a 3-D dem-
onstration. Cells were wounded in a similar fashion as in Fig. 1 and recorded 
following wounding over 7 h. When treated with IL-8, cells migrated earlier 
(B) and faster than the control cells (B). (A and B) mean of 8 traces, (C) Cell 
modelling. *p<0.01 vs. control cells. rhIL-8, recombinant human IL-8.
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Figure 3. rhIL-8 had a significant impact on the adhesion of keratinocytes, assessed using the ECIS method. Cells were added to the ECIS arrays, pre-treated with 
10% FCS; the adhesion was traced immediately following addition of the cells. (A) Traces of adhesion, (B) normalised resistance of adhesion traces, (C and D) 3-D 
modelling of adhesion (as resistance). rhIL-8, recombinant human IL-8; ECIS, electric cell-substrate impedance sensing; FCS, fetal calf serum; WT, wild-type.
Figure 4. Potential signalling pathways involved in IL-8-mediated migra-
tion in HaCaT cells. (A) ECIS traces following electric wounding, (B) Mean 
changes of resistance. *p<0.05 vs. without IL-8. n=4. rhIL-8, recombinant 
human IL-8; ECIS, electric cell-substrate impedance sensing.
Figure 5. The levels of IL-8 receptor transcript expression in acute and 
chronic wounds. (A) IL-RA, (B) IL-8RB. The levels shown are the medians. 
*p<0.05 vs. acute wound tissues, as shown by the Mann-Whitney U test. 
IL-8R, IL-8 receptor.
  A   B
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Discussion
The present study reports that the status of the IL-8R, IL-8RB, 
is linked to clinical outcome in chronic wounds. Furthermore, 
this study further demonstrates that IL-8 has a direct impact 
on the migration of human keratinocytes.
We show that IL-8 has a profound effect on the migration of 
keratinocytes. It has previously been shown that IL-8 may act 
as a chemoattractant to keratinocytes, in that keratinocytes may 
respond to the gradient change of IL-8. In the present study, we 
used a novel method, ECIS, and an electrical wounding model. 
In this model, cells were wounded by an electric current, and 
the migration of cells from the surrounding areas was traced 
in the prescence of IL-8. The data presented here, therefore, 
clearly indicate that IL-8 also induces migration, most likely 
in the form of chemokinesis, of keratinocytes, another crucial 
form of cell migration.
CXC chemokine-induced chemotaxis involves a number of 
intracellular signalling pathways, classically the JAK, Src/PI3K, 
FAK and PLC pathways (27-30). The present study clearly 
demonstrates that the IL-8-induced migration of HaCaT cells 
(chemokinesis) critically requires the PLC-γ pathway, in that 
the PLC-γ inhibitor suppressed IL-8-induced migration and 
completely blocked the action of IL-8. By contrast, FAK, ARP2/3 
and ERK inhibitors do not appear to signficantly affect the action 
of IL-8. 
It has previously been shown that IL-8 is associated with 
wound healing in vivo (19). In an IL-8RB knockout mouse 
model, it was found that the rate of wound healing was reduced, 
thought to be the result of a reduction in monocyte recruitment 
to the wounding space, reduced angiogenesis and re-epitheliali-
sation. In this study, we provide further evidence that IL-8 itself 
has a direct impact on the re-epithelialisation of keratinocytes.
Despite the evidence, in vitro and in vivo, that IL-8 and 
IL-8Rs have an impact on wound healing, it is not known 
how the IL-8Rs are linked to the healing of human wounds. 
The present study provides first-line evidence that in chronic 
wounds, the levels of IL-8RA and, in particular, IL-8RB are 
significantly lower when compared with acute wound tissues. 
This is noteworthy, as it indicates that a loss or reduction of 
IL-8Rs may be an essential part of the mechanisms of why 
wounds are not healing or responding to IL-8. It is highly plau-
sible that the low levels of IL-8Rs rendered cells necessary for 
wound healing irresponsive or poorly responsive to IL-8, a cyto-
kine that appears to be involved in the wound healing process. 
Together with in vitro data and evidence from animal studies, it 
is suggested that IL-8 and IL-8Rs are a useful indicator for the 
nature of healing of a given wound. This further suggests that 
IL-8 may be a means to manipulate the healing of wound tissues 
and may have a therapeutic value. This is likely to be manifested 
by the direct effect of IL-8 on keratinocytes, on endothelial 
cells, through the induction of angiogenesis, on immune cells 
for combating infection and fibroblasts during the tissue model-
ling process of wound healing. Of course, IL-8 is not at all a 
clear wound healer without concerns. It has been shown that 
IL-8RB may mediate skin carcinogenesis when overexpressed 
or repeatedly induced (30).
In conclusion, IL-8 has a profound impact on keratinocytes 
by increasing the rate of cell migration. Together with the 
observation that IL-8Rs are markedly lower in chronic than in 
acute wounds, it is suggested that IL-8 and its receptors have 
prognostic and therapeutic value in difficult-healing wounds.
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